U.S. Markets close in 4 hrs 24 mins
  • S&P 500

    3,775.66
    -7.62 (-0.20%)
     
  • Dow 30

    30,186.13
    -87.74 (-0.29%)
     
  • Nasdaq

    11,154.94
    +6.30 (+0.06%)
     
  • Russell 2000

    1,758.05
    -4.64 (-0.26%)
     
  • Crude Oil

    88.43
    +0.67 (+0.76%)
     
  • Gold

    1,721.20
    +0.40 (+0.02%)
     
  • Silver

    20.61
    +0.07 (+0.35%)
     
  • EUR/USD

    0.9835
    -0.0151 (-1.5146%)
     
  • 10-Yr Bond

    3.8140
    +0.0550 (+1.46%)
     
  • Vix

    29.32
    +0.77 (+2.70%)
     
  • GBP/USD

    1.1190
    -0.0285 (-2.4808%)
     
  • USD/JPY

    144.7950
    +0.5960 (+0.4133%)
     
  • BTC-USD

    20,100.15
    +162.66 (+0.82%)
     
  • CMC Crypto 200

    457.52
    -5.60 (-1.21%)
     
  • FTSE 100

    7,006.24
    -46.38 (-0.66%)
     
  • Nikkei 225

    27,311.30
    +190.77 (+0.70%)
     

Agenus (NASDAQ:AGEN) shareholders have endured a 64% loss from investing in the stock a year ago

·2 min read

Agenus Inc. (NASDAQ:AGEN) shareholders should be happy to see the share price up 23% in the last month. But that isn't much consolation to those who have suffered through the declines of the last year. Like an arid lake in a warming world, shareholder value has evaporated, with the share price down 64% in that time. The share price recovery is not so impressive when you consider the fall. It may be that the fall was an overreaction.

So let's have a look and see if the longer term performance of the company has been in line with the underlying business' progress.

See our latest analysis for Agenus

Given that Agenus didn't make a profit in the last twelve months, we'll focus on revenue growth to form a quick view of its business development. Shareholders of unprofitable companies usually expect strong revenue growth. As you can imagine, fast revenue growth, when maintained, often leads to fast profit growth.

Agenus grew its revenue by 266% over the last year. That's well above most other pre-profit companies. In contrast the share price is down 64% over twelve months. Yes, the market can be a fickle mistress. This could mean hype has come out of the stock because the bottom line is concerning investors. We'd definitely consider it a positive if the company is trending towards profitability. If you can see that happening, then perhaps consider adding this stock to your watchlist.

You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values).

earnings-and-revenue-growth
earnings-and-revenue-growth

Take a more thorough look at Agenus' financial health with this free report on its balance sheet.

A Different Perspective

While the broader market lost about 20% in the twelve months, Agenus shareholders did even worse, losing 64%. Having said that, it's inevitable that some stocks will be oversold in a falling market. The key is to keep your eyes on the fundamental developments. Regrettably, last year's performance caps off a bad run, with the shareholders facing a total loss of 9% per year over five years. We realise that Baron Rothschild has said investors should "buy when there is blood on the streets", but we caution that investors should first be sure they are buying a high quality business. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. For example, we've discovered 4 warning signs for Agenus (1 shouldn't be ignored!) that you should be aware of before investing here.

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies we expect will grow earnings.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.